Catalyst
Slingshot members are tracking this event:
Kite Expects Phase 1 Data in 2016 for huCD19 Study Evaluating KTE-C19 in B-Cell Malignancies
- Source Link:
- http://ir.kitepharma.com/events.cfm
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KITE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 14, 2017
Occurred Source:
http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=1017388
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1 Data, Hucd19, Kte-c19, B-cell Malignancies
